Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BMS-262084 is a potent selective β-lactam trypsin inhibitor with therapeutic potential in the treatment of asthma.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 2,120.00 | |
50 mg | 8-10 weeks | $ 2,780.00 | |
100 mg | 8-10 weeks | $ 3,700.00 |
Description | BMS-262084 is a potent selective β-lactam trypsin inhibitor with therapeutic potential in the treatment of asthma. |
Targets&IC50 | FXIa:2.8 nM (IC50), Tryptase:5 nM (IC50) |
Synonyms | BMS 262084, I0IR71971G, UNII-I0IR71971G, CHEMBL71037 |
Molecular Weight | 425.48 |
Formula | C18H31N7O5 |
CAS No. | 253174-92-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BMS-262084 253174-92-4 CHEMBL 71037 CHEMBL-71037 BMS262084 BMS 262084 I0IR71971G UNII-I0IR71971G CHEMBL71037 inhibitor inhibit